US 11858927
Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted A61PA61P1/16A61P19/02
Quick answer
US patent 11858927 (Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death) held by HEPAREGENIX GMBH expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HEPAREGENIX GMBH
- Grant date
- Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/16, A61P19/02, A61P25/00